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The NADPH oxidases are important transmembrane proteins producing reactive oxygen species (ROS).
Within the Nox family, different modes of activation can be discriminated. Nox1-3 are dependent on
different cytosolic subunits, Nox4 seems to be constitutively active and Nox5 is directly activated by
calcium. With the exception of Nox5, all Nox family members are thought to depend on the small
transmembrane protein p22phox. With the discovery of the CRISPR/Cas9-system, a tool to alter genomic
DNA sequences has become available. So far, this method has not been widely used in the redox com-
munity. On such basis, we decided to study the requirement of p22phox in the Nox complex using
CRISPR/Cas9-mediated knockout. Knockout of the gene of p22phox, CYBA, led to an ablation of activity of
Nox4 and Nox1 but not of Nox5. Production of hydrogen peroxide or superoxide after knockout could be
rescued with either human or rat p22phox, but not with the DUOX-maturation factors DUOXA1/A2.
Furthermore, different mutations of p22phox were studied regarding the inﬂuence on Nox4-dependent
H2O2 production. P22phox Q130* and Y121H affected maturation and activity of Nox4. Hence, Nox5-
dependent O2
 production is independent of p22phox, but native p22phox is needed for maturation of
Nox4 and production of H2O2.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The Nox family of NADPH oxidases is an important source of
reactive oxygen species (ROS). Through ROS, Nox enzymes play
diverse roles in cellular signaling, regulation of gene expression,
cell differentiation and posttranslational protein modiﬁcations [4].
In mammals, seven members are expressed and grouped accord-
ing to their mode of activation. Nox1, Nox2 and Nox3 are activated
by an assembly with speciﬁc cytosolic proteins, which translocate
to the plasma membrane. On the other hand, Nox5 and DUOX1 as
well as DUOX2 (Dual oxidase 1 and 2) are directly activated byB.V. This is an open access article u
paced short palindromic re-
man embryonic kidney 293
K293 cells stably expressing
-HEK293, HEK293 cells ex-
re Physiologie, Fachbereich
, 60590 Frankfurt am Main,
. Brandes).calcium in an EF-hand motif dependent manner. To our current
knowledge, Nox4, in contrast, is constitutively active and ROS
production of the enzyme is mainly controlled by its expression
level [5].
For DUOX1 or DUOX2, maturating factors are needed to achieve
proper expression and activity. The small transmembrane protein
p22phox/CYBA (Cytochrome B-245 Alpha Chain) was described to
be essential for Nox1, Nox2 and Nox3 maturation, stabilization and
activation [2,20,21,31]. P22phox has been found to interact with
Nox4, indicating importance for Nox4 activity and localization
[2,18,19]. The exact site where p22phox interacts and activates
Nox4 appears non-canonical with respect to Nox1, Nox2 or Nox3
[17,31]. P22phox consists of two (or four) predicted transmem-
brane domains and an extended C-terminus with a prolin-rich
region, which is required for the assembly with p47phox or NoxO1
to membrane-bound Nox1, Nox2 and Nox3 [5,31]. This feature is
dispensable for Nox4 indicating a different role for the p22phox-
Nox4 activation [16,17]. Mutations in p22phox are associated with
a loss of function leading to severe immunodeﬁciency called
chronic granulomatous disease (CGD), with inability to clear somender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Further analysis of the structural and functional role of
p22phox are necessary not just for understanding the Nox2-de-
pendent pathogen defense, but also for the analysis of Nox4, as a
protective cardiovascular enzyme.
In the kidney, the endothelium and ﬁbroblasts, Nox4 is the
predominantly expressed Nox homolog [1,7,11]. Nox4 is funda-
mentally different to the other Nox enzymes and exhibits a dif-
ferent dependency on p22phox. Approaches to study p22phox-
Nox4 interaction like the p22phox mutant mouse nmf333 could
only partially reveal the mechanisms underlying the relevant
protein interaction [17,22]. There is, however, no doubt that
p22phox is important for Nox4 and changing the expression of
this ubiquitously expressed protein alters H2O2 formation of most
cells overexpressing Nox4 [2,16,26]. In previous work, Löhneysen
et al. inserted mutations in p22phox which reduced Nox4-de-
pendent H2O2 formation. A dual tryptophan motif in the N-term-
inal amino acids (aa) 6-11 was found necessary for Nox4 activity
and localization. P22phox mutants of the ﬁrst ﬁve -but not ten- aa
did not impact on activity and are thus tolerated as well as dele-
tion of aa after residue 130, which are involved in binding of
p47phox or NoxO1 and activation of Nox1-3. In line with this,
p22phox mutations in the C-terminal prolin-rich region (P156Q-
P160Q) are tolerated for Nox4-derived H2O2 formation [16,17].
Point mutations in the putative membrane spanning domain are
less well tolerated, e.g. non-conservative exchange of arginine 90
(R90Q) abolished Nox4-dependent H2O2 production [17,27].
Given that protein abundance of p22phox is largely controlled
by posttranscriptional mechanisms and that a few studies on
complete knockout of p22phox have been performed so far, we set
out to study the requirement of p22phox in the Nox complex using
Clustered regulatory interspaced short palindromic repeats
(CRISPR)/CRISPR-associated protein 9 (Cas9)-mediated knockout.
CRISPR/Cas9-mediated genome editing offers a fast and easy way
to manipulate genomes in cell culture requiring just a 20-nu-
cleotide targeting sequence, called guide RNA (gRNA). In one var-
iant of RNA-guided Cas9 nuclease, the BbsI enzyme-mediated
knockout strategy, a pair of gRNAs have been successfully used to
mediate microdeletions e. g. in the Homeobox protein EMX1 [25].
The p22phox gene (CYBA) is located on the long arm of chro-
mosome 16 and consists of six exons with a total length of approx.
8500 nucleotides [10]. As the ﬁrst exon is found in all predicted
variants of p22phox, gRNAs targeting or ﬂanking the exon 1 were
chosen for microdeletions. In this study CRISPR/Cas9-mediated
p22phox HEK (human embryonic kidney cells) knockout cell lines
were used to study the role of endogenous p22phox on the ex-
pression, maturation and activity of Nox4, but also Nox1 and Nox5.
Moreover, truncated and modiﬁed p22phox variants with essential
N-terminal and membrane domain mutations were analyzed in a
constitutive and inducible Nox4-overexpressing and p22phox-
deﬁcient cellular system.2. Materials and methods
2.1. Mutagenesis of p22phox
The QuikChange II XL Site-Directed Mutagenesis Kit (#200521,
Agilent) was used to mutate p22phox. Primers were designed with
the web-based QuikChange Primer Design Program. Brieﬂy, the
plasmid coding for human p22phox (kindly provided by Leto, NIH)
was used for mutant strand synthesis reaction with PfuUltra HF
DNA polymerase (2.5 U/ml) according to the kit, followed by a DpnI
(10 U/ml) digestion of the original strand. The mutated plasmid was
transformed into XL10-Gold Ultracompetent cells, the generated
plasmid was puriﬁed with the GenJet Plasmid Miniprep Kit(K0503, Thermo Scientiﬁc). Mutations were veriﬁed by sequen-
cing. The following primers were used for the introduction of
single amino acid mutation: CYBA A91stop 5′-GAG AGC AGG AGA
TGC AGG ACC TAC CGA ACA TAG TAA TTC CTG G-3′ and 5′-CCA GGA
ATT ACT ATG TTC GGT AGG TCC TGC ATC TCC TGC TCT C-3′; CYBA
E5A 5′-CCA CAT GGC CCA CGC GAT CTG CCC CAT-3′ and 5′ATG GGG
CAG ATC GCG TGG GCC ATG TGG-3; CYBA E12A 5′CCA GCG CCT
GCG CGT TGG CCC AC-3′2 and 5′-GTG GGC CAA CGC GCA GGC GCT
GG-3′; CYBA G110stop 5′-CTG CTG GCC ACC ATC CTT TAG ACC GCC
TGC-3′and 5′-GCA GGC GGT CTA AAG GAT GGT GGC CAG CAG-3′;
CYBA I110C 5′-CCG CCA GTA GGT AGC AGC CGC TCG CAA TGG-3′
and 5′-CCA TTG CGA GCG GCT GCT ACC TAC TGG CGG-3; CYBA
Q130stop 5′-TGG GCG TCC ACT ACT CGC CAC GCA C-3′ and 5′-GTG
CGT GGC GAG TAG TGG ACG CCC A-3′; CYBA R90Q 5′-GCC CTT TAC
CAG GAA TTA CTA TGT TGA GGC CGT CCT GCA T-3′and 5′-ATG CAG
GAC GGC CTC AAC ATA GTA ATT CCT GGT AAA GGG C-3′; CYBA
R90stop 5′-ATG CAG GAC GGC CTA AAC ATA GTA ATT CCT GGT AAA
GGG C-3; CYBA r90stop 5′-GCC CTT TAC CAG GAA TTA CTA TGT TTA
GGC CGT CCT GCA T-3; CYBA Y121H 5′-CCG CCA GTA GGT GGA TGC
CGC TCG C-3′ and 5′-GCG AGC GGC ATC CAC CTA CTG GCG G-3′ as
well Nox5 T493K 5′-CAG GAG CAC TGC TGA TCT TGA AGG GGT GCC
ACTC-3′ and 5′-GAG TGG CAC CCC TTC AAG ATC AGC AGT GCT CCT
G-3′.
2.2. Cell culture
Human embryonic kidney 293 cells (HEK293) cells were ob-
tained from ATCC (Manassas, VA, USA) and cultured in Modiﬁed
Eagle's Medium (MEM, Gibco) supplemented with fetal calf serum
(FCS; 8%), non-essential amino acids (0.1 mM), sodium pyruvate
(1 mM) and gentamycin (50 μg/mL) in a humidiﬁed atmosphere
(5% CO2, 37 °C). HEK293 cells expressing human Nox4 with a tet-
racycline-inducible tet-on operator (Nox4-pDEST30) were kindly
provided by K.H. Krause (University of Geneva, Switzerland) [29].
Induction with 1 mg/mL tetracycline was performed for 24 h in
HEK medium. HEK293 cells stably expressing human Nox4 (Nox4-
HEK293) were generated as described before using lentiviral
transfection and selection [12].
2.3. Transfection of Nox constructs
Transient transfection of HEK293 cells was performed using
Lipofectamine 2000 (#11668027, ThermoFisher) and 0.75 mg/mL
plasmid DNA according to the manufacturer's instructions. Cells
were kept in culture for 48 h. DUOXA1 and DUOXA2 plasmids
were kindly provided by H. Grasberger (University of Michigan
Medical School, Michigan).
2.4. Cloning of pHAGE2-NoxO1-NoxA1-Nox1 for transient
overexpression
To clone NoxO1, NoxA1 and Nox1 as lentiviral triple over-
expression plasmid under control of the human EF1a promoter, in
which NoxO1 and NoxA1 are divided by a 2A peptide (F2A) and
NoxA1 and Nox1 separated by an internal ribosome entry site
(IRES), PCR ampliﬁcations of NoxO1, NoxA1 and Nox1 were per-
formed from pCMV6-NoxO1 (NM_172167, #RC214973, Origene),
pCMV6-NoxA1 (NM_001256067, #RC234211, Origene) and
pCMV6-Nox1 (NM007052, #RC210426, Origene) Human cDNA
ORF clones with the following primers: NoxO1 5′-ATA GCG GCC
GCC ATG GCA GGC CCC CGA TAC CCA GTT TCA GTG-3′ and 5′-ATT
TGC TTA GCC CCT GCT CCG TCG TGG GGT GCG GC-3′, NoxA1 5′-ATT
AGC TAG CAT GGC CTC TCT GGG GGA CCT GGT GCG-3′ and 5′-ATT
TGG ATC CTT AGG GCT GAT CTC CCT GCT GGG ATC GGG-3′ and 5′-
ATA TTA CAT ATG ATG GGA AAC TGG GTG GTT AAC CAC-3′ and 5′-
ATT GAT TAG GAT CTA TCG ACT CAA AAA TTT TCT TTG TTG AAG
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NoxA1 was ampliﬁed with 5′-ATT TGC TAA GCA CGG GTT CGG GTG
CGC CAG TAA AGC AGA C-3′ and 5′-ATT TGC TAG CTG GAC CTG GAT
TTG ACT CTA CAT CAC-3′ from pHAGE2, which was a gift from G.
Mostoslavsky (Boston University, MA, USA) [30]. PCR products
were cut in the following way to achieve a speciﬁc order of in-
tegration into pHAGE2: NoxO1 (NotI/BlpI (#ER0591, #ER0091,
ThermoFisher)), F2A (BlpI/NheI (#ER0091, #ER0972, Thermo-
Fisher)), NoxA1 (NheI/BamHI (#ER0972, #ER0055, ThermoFisher))
and Nox1 (NdeI/BsaBI (#ER0581, #ER1711, ThermoFisher)). In a
ﬁrst ligation reaction, pHAGE2 cut by BamHI/NotI (#ER0055,
#ER0591, ThermoFisher) was used to be ligated with restricted
NoxO1, F2A and NoxA1. This intermediate product was puriﬁed
and further cut by NdeI/BsaBI (#ER0581, #ER1711, ThermoFisher)
to be ligated in a second reaction with restricted Nox1. The ﬁnal
plasmid (pHAGE2-NoxO1-NoxA1-Nox1) was puriﬁed and
sequenced.
2.5. Cloning of pHAGE2-Nox5 for stable overexpression
To clone pHAGE2-Nox5 for lentiviral overexpression under the
control of the human EF1a promoter, Nox5 was ampliﬁed from
pCMV6-Nox5 (NM_001184779) Human cDNA ORF Clone
(#RC230471, Origene) with the following primers: 5′-ATT GCG GCC
GCC ATG AAC ACA TCT GGA GAC CCA GCC CAG AC-3′ and 5′-ATT
TGA TTA GGA TCT ATC GAC CTA GAA ATT CTC TTG GAA AAA TCT
G-3′. pHAGE2 was a gift from Gustavo Mostoslavsky [30]. Nox5
PCR product and pHAGE2 were cut with NotI/BsaBI (#ER0591,
#ER1711, ThermoFisher) followed by ligation. Plasmid was puriﬁed
and sequenced.
2.6. Lentiviral transfection of HEK293 cells with pHAGE2-Nox5
Vesicular stomatitis virus (VSV) pseudotyped lentivirus was
produced by transfection of HEK293T cells with pHAGE2-Nox5 in
combination with HGPM2, Tat1B, Rev1B and VSV-G, which were a
gift from Bianling Liu. Viral supernatants were collected, con-
centrated and snap-frozen after four days. Transfection of 70%
subconﬂuent HEK293 with Nox5 viral particles was performed for
12 days, followed by clonal expansion.
2.7. CRISPR/Cas9
The web interface of CRISPR design (http://crispr.mit.edu/) was
used to develop gRNAs. Off-target activity was evaluated ad-
ditionally with Blastn (https://blast.ncbi.nlm.nih.gov/Blast.cgi). The
pSpCas9(BB)-2A-Puro (PX459) v2.0 was a gift from Feng Zhang
(Addgene plasmid # 62988) and used as cloning backbone.
CRISPR/Cas9 was carried out similar as in [14,25]. Brieﬂy, phos-
phorylation and annealing was performed with the following oli-
gonucleotides harboring a BbsI overhang: For (A) CYBA_1_Exon1
with 5′-CAC CGG CCG GGT TCG TGT CGC CAT G-3′ and 5′-AAA CCA
TGG CGA CAC GAA CCC GGC C-3′, for (B) CYBA_2_Exon1 with 5′-
CAC CGG GAC GCC AGC GCC TGT TCG T-3′ and 5′-AAA CAC GAA
CAG GCG CTG GCG TCC C-3′, for (C) CYBA_3_Exon1 with 5′-CAC
CGG GCC ATG TGG GCC AAC GAA C-3′ and 5′-AAA CGT TCG TTG
GCC CAC ATG GCC C-3′, for (D) CYBA_1_Intron1 with 5′-CAC CGG
TGC ACG TCA GGG ACG GTG G-3′ and 5′-AAA CCC ACC GTC CCT
GAC GTG CAC C-3′, for (E) CYBA_2_Intron1 with 5′-CAC CGC GGG
ACC TCG GGC TAC TTA C-3′ and 5′-AAA CGT AAG TAG CCC GAG GTC
CCG C-3′, for (F) CYBA_3_Intron1 with 5′-CAC CGC CCA CCC TGT
AAG TAG CCC G-3′ and 5′-AAA CCG GGC TAC TTA CAG GGT GGG
C-3′ and for (G) CYBA_2_5′UTR with 5′-CAC CGC GGG GTT CGG
CCG GGA GCG C-3′ and 5′-AAA CGC GCT CCC GGC CGA ACC CCG
C-3′. Afterwards, BbsI (#FD1014, ThermoFisher) mediated diges-
tion and T7 DNA ligase (#M0318L, NEB) directed ligation wasperformed followed by PlasmidSafe exonuclease treatment
(#E3101K, Epicenter/Biozym) according to the manufacturers
protocol. Plasmids were puriﬁed and sequenced. After transfection
of the indicated combinations of pSpCas9(BB)-2A-Puro-gRNAs
(Fig. 1B), positive cells were selected using puromycin (2 μg mL1)
for ﬁve days prior to clonal expansion. Empty pSpCas9(BB)-2A-
Puro was used as negative control.
2.8. Determination of ROS production
ROS production was measured as described before [24,26]. As
probe, luminol (100 mM, #123072, Sigma) catalyzed by horseradish
peroxidase (HRP, 1 U/mL, #P6782, Sigma) or L012 (250 mM, #120-
04891, Wako) was used and measured in a TriStar2 Multimode
Reader (LB942, Berthold, Wildbad, Germany).
2.9. Western blot analysis
Triton-lyzed samples were substituted with sample buffer
(8.5% glycerin, 2% SDS, 6.25% TRIS/HCl pH 6.8, 20 mM DTT, 0.013%
bromphenol blue) but not heat-denatured. As a reducing agent
TCEP (tris(2-carboxyethyl)phosphine, Thermo Scientiﬁc) was used
as described before [28]. Protein amounts were determined by
Bradford protein assay. Proteins were separated by SDS-PAGE,
substituted to Western analysis and detected by primary anti-
bodies. Infrared-ﬂuorescent-labeled secondary antibodies were
used and visualized in the Odyssey system (Licor, Bad Homburg,
Germany). Nox4 was detected by an anti-Nox4 antibody (1:2000)
reported by Anilkumar et al. [3]. Primary antibodies against Nox1
(Mox1, #sc-5821, 1:500), Nox5 (#sc-67006, 1:500) and p22phox
(#sc-20781, 1:500) were purchased from Santa Cruz, β-Actin
(#A1978, 1:2000) was obtained from Sigma.
2.10. RNA isolation and RT-qPCR
RNA was isolated with the RNA Mini-Kit (#BS67.311, Bio&Sell)
according to the manufacturer's instructions. Random hexamer
primers (#C1181, Promega) and SuperScript III Reverse Tran-
scriptase (RT, #18080044 ThermoFisher) were used for reverse
transcription. A non-RT control was used. CDNAwas used for semi-
quantitative real-time PCR using iQ™ SYBRs Green Supermix
(#1708880, BioRad) in a Mx3000P qPCR cycler (Agilent Technol-
ogies). Relative mRNA expression was normalized to RNA Poly-
merase IIa (POLR2A) and analyzed by the delta-delta-Ct method.
Results are shown as relative to the corresponding control. Primer
sequences are summarized in Table 1.
2.11. Statistical analysis
Values are mean7SEM (standard error of mean) if not other-
wise indicated. Statistical analysis was carried out using Prism
3.02. For multiple testing ANOVA followed by post hoc testing
(Bonferroni's Multiple Comparison Test) was used, unless other-
wise indicated; n indicates the number of individual experiments.
Densitometry was performed using the Odyssey-software (Image
studio lite 5.0) and normalized to corresponding reference protein
β-actin. A p-value of less than 0.05 was considered statistically
signiﬁcant (*po0.05; **po0.01; ***po0.001).3. Results
3.1. CRISPR/Cas9-mediated knockout of CYBA/p22phox
To study the role of endogenous p22phox on Nox-dependent
ROS formation, different guide RNAs (gRNAs) against the p22phox
Fig. 1. CRISPR/Cas9-mediated knockout of p22phox in Nox4/tetNox4-HEK293 cells. A, Schematic representation of the designed guide RNAs (gRNA) targeting 5′UTR (un-
translated region; 1&7, green), exon 1 (2&3, red) or intron 1 (4–6, blue) of the p22phox gene (CYBA; on chromosome 16). Image taken from UCSC genome browser (http://
genome-euro.ucsc.edu/index.html) is modiﬁed. B, Used combinations (Combi.) of different gRNAs A-G for transfection of HEK293 cells. C, D, Representative Western blot for
p22phox, Nox4 and β-Actin protein expression in empty vector control cells (Vec) and after CRISPR/Cas9-mediated p22phox knockout with different combinations or single
gRNAs as indicated and deﬁned in B. Every combination (combi.) was tested in Nox4-HEK293 (C) or tetNox4-HEK293 cells (D). (For interpretation of the references to color in
this ﬁgure legend, the reader is referred to the web version of this article).
Table 1
RT-qPCR Primer.
Gen Sequence (5′–3′)
h POLR2A forward GCACCACGTCCAATGACAT
reverse GTGCGGCTGCTTCCATAA
h NOX4 forward TCCGGAGCAATAAGCCAGTC
reverse CCATTCGGATTTCCATGACAT
h CYBA forward TACTATGTTCGGGCCGTCCT
reverse CACAGCCGCCAGTAGGTA
K.-K. Prior et al. / Redox Biology 9 (2016) 287–295290gene CYBA were designed (Fig. 1A, B). Seven different gRNAs were
transfected into stable Nox4- (Fig. 1C; Nox4-HEK293) or tetra-
cycline-inducible Nox4-HEK293 cells (Fig. 1D; tetNox4-HEK293)
and CRISPR/Cas9-mediated knockout was validated by Western
Blot. Whereas single gRNA usage resulted in p22phox protein re-
duction, most of the gRNA combinations displayed loss of p22phox
in both HEK293 cell types (Fig. 1B, C, D). Complete loss of p22phox
was achieved with a combination of three gRNAs (Fig. 1B and C;
combination 17) or all seven gRNAs (Fig. 1B and C; combination
18). For the subsequent experiments, the most effective combi-
nations were used with cells targeted with two or three gRNAs
with the combinations 1, 4, 7, 8, 10 and 17.
3.2. Knockout of endogenous p22phox reduces Nox4-dependent
H2O2 production, but not Nox4 expression
To test the inﬂuence of CRISPR/Cas9-mediated p22phox
knockout on Nox4-dependent ROS production, Nox4 constitutively
overexpressing (Fig. 2 left) and induced tetNox4-overexpressing
HEK293 cells (Fig. 2 right, tetracycline 1 mg/mL, 24 h) were studied
in the luminol/HRP assay. P22phox and Nox4 mRNA as well asprotein expression were studied in the cells subjected to ROS
measurements (Fig. 2A, B, E, F, G, H). Deletion of p22phox resulted
in a strong reduction of ROS production, and the extent of the
effect correlated with the p22phox mRNA and protein expression
but not with Nox4 mRNA or protein expression. Interestingly, the
inhibitory effect on ROS formation appeared more prominent in
the constitutively overexpressing than in the tet-inducible cells
(Fig. 2C and D). Although deletion of p22phox lowered ROS for-
mation, it certainly did not abolish it. This effect could potentially
be a consequence of insufﬁcient transfection efﬁciency.
3.3. Knockout of endogenous p22phox completely abolishes Nox4-
dependent H2O2 production
To generate deﬁned p22phox-deﬁcient cells, Nox4- and tet-
Nox4-HEK293 cells, harboring the most effectively reduced
p22phox expression (gRNA combination 1 and combination 10),
were clonally expanded. Multiple clones were tested on p22phox
expression and H2O2 production and three of those were chosen
for the subsequent studies. The three tested clones of either con-
stitutive expressing Nox4-HEK293 cells (Fig. 3A) or tetracycline-
induced tetNox4-HEK293 cells (Fig. 3B) displayed a complete loss
of H2O2 production measured by luminol/HRP assay, in compar-
ison to the empty vector control. Despite some unspeciﬁc bands in
the Western blot, p22phox could not be detected in all three
clonally expanded CRISPR/Cas9-knockout cell lines (C1 or C10). As
the starting population of the clonal expansion was variable re-
garding Nox4 expression, Nox4 expression level also varied in the
different p22phox-knockout cell lines. Hence, the H2O2 production
is not dependent on Nox4 expression as seen in the Western blot,
but on p22phox expression only. The clones C1-1 and C10-1 were
used for all following experiments.
Fig. 2. Nox4-dependent H2O2 production and expression in p22phox-CRISPR/Cas9 knockout Nox4/tetNox4-HEK293 cells. A, B, Representative Western blot with densito-
metry for p22phox protein expression normalized to β-Actin in empty vector (Vec) control cells and after CRISPR/Cas9-mediated p22phox knockout (combinations of gRNAs:
1, 4, 8, 10, 17) in Nox4-HEK293 (A) or induced tetNox4-HEK293 cells (B). C, D, Relative luminol/HRP assay in controls (Vec) and after CRISPR/Cas9-mediated p22phox
knockout (combi. 1, 4, 8, 10, 17) in Nox4-HEK293 (C) or tetNox4-HEK293 cells (D). CU (chemiluminescence unit) was normalized to protein amount (μg) and control (Vec). E–
H, Normalized, relative mRNA level for CYBA (E, F) and NOX4 (G, H) in control (Vec) and CRISPR/Cas9-mediated p22phox knockout (combi. 1, 4, 8, 10, 17) in Nox4-HEK293 (E,
G) or induced tetNox4-HEK293 cells (F, H). nZ3, mean7SEM,*po0.05; **po0.01; ***po0.001 relative to the corresponding vector treated cells (Vec).
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p22phox, but not with DUOXA1 or DUOXA2
The clonally expanded p22phox knockout cells are an ideal tool
for reconstitution experiments. Transfection of the cells with
plasmids coding for human p22phox (hp22) as well as rat p22phox
(rp22) restored the ROS production in Nox4-HEK293 cells as well
as tetNox4-HEK293 cells (Fig. 4A and B). To test the hypothesis
that DUOX1/2 maturation factors may substitute p22phox,
DUOXA1 (DA1) and/or DUOXA2 (DA2) were also transfected. Im-
portantly, the DUOX maturation factors did not affect ROS for-
mation (Fig. 4A and B) and therefore cannot substitute p22phox.3.5. P22phox is required for Nox1-, but not Nox5-dependent O2

production
To test whether other Nox isoforms are also inﬂuenced by the
knockout of endogenous p22phox, p22phox deﬁcient cells were
transiently transfected with either a NoxO1-NoxA1-Nox1 expres-
sing plasmid or with a Nox5 plasmid. Despite knockout of
p22phox, Nox5 transfected cells exhibited PMA (phorbol 12-myr-
istate 13-acetate; 100 nM)-stimulated ROS production as detected
by L012 chemiluminescence (Fig. 5A, CYBA KO1&2). A similar ef-
fect was observed in stably transduced Nox5-HEK293 cells sub-
jected to CRISPR/Cas9 p22phox knockout with different
Fig. 3. Nox4-dependent H2O2 production in subclonal expanded p22phox-CRISPR/Cas9 knockout Nox4/tetNox4-HEK293 cells. Either Nox4-HEK293 (A) or induced tetNox4-
HEK293 cells (B) were transfected with empty vector (Vec) or gRNA combination 1 or 10, selected with puromycin and subclonally expanded. Each clone is named according
to the vector control (Vec) or gRNA combination (1 or 10) and ongoing number (e.g. C1-1). Relative luminol/HRP assay was performed in subclonally expanded control cells
(Vec) or CRISPR/Cas9-mediated p22phox knockout (combinations 1 or 10) Nox4-HEK293 (A) or tetNox4-HEK293 cell lines (B). Also shown are representative Western blots
for p22phox, Nox4 and β-Actin. nZ3, mean7SEM, ***po0.001 relative to corresponding vector clones.
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Fig. 4. Nox4-dependent H2O2 production in p22phox-CRISPR/Cas9 knockout Nox4/
tetNox4-HEK293 cells. Either subclonally expanded p22phox knockout Nox4-
HEK293 (C1-1 and C10-1; A) or tetNox4-HEK293 cells (C1-1 and C10-1; B) were
transiently transfected (overexpression: OE) with human (hp22), rat p22phox
(rp22) or DUOXA1 (DA1), DUOXA2 (DA2) or a combination of both (DA1/2). Relative
luminol/HRP assay in Nox4-HEK293 (A) or induced tetNox4-HEK293 cells (B) was
performed. n¼6, mean7SEM, *po0.05; **po0.01; relative to the corresponding
control cells.
K.-K. Prior et al. / Redox Biology 9 (2016) 287–295292combinations of gRNAs (1, 4, 7, 8, 10, 17) (Fig. 5B). In contrast,
p22phox-deﬁciency completely abolished Nox1-dependent O2
production (Fig. 5C, CYBA KO1&2), whereas Nox1 expression was
not changed (Fig. 5C). Thus, Nox5 but not Nox1-mediated ROS is
independent of p22phox in contrast to Nox1 or Nox4.3.6. Analysis of p22phox mutants and their effect on Nox4-depen-
dent ROS production
To gain insights into the function of p22phox in Nox4-depen-
dent ROS production, mutations were studied. First, C-terminal
truncations were analyzed (Fig. 6A and B). Truncation beyond
Q130 resulted in a complete loss of enzyme activity, whereas the
protein truncated at Q130 still showed some ROS activity. Inter-
estingly, this effect was more pronounced in the tetNox4-HEK293
cells as compared to the Nox4 stably expressing cells, potentially
suggesting that the dynamic of Nox4 protein formation is relevant
for this mutation. Importantly, these observations are in stark
contrast to a previous publication, which reported that a p22phox-
Q130 truncation was fully active [17]. Truncations at aa90, aa91 or
aa110 were indispensable for Nox4 activity (Fig. 6A and B).
As several CGD patients carry the p22phox missense mutation
R90, we also tested a R90Q mutant [27] on its effect on Nox4
(Fig. 6C and D). The mutation not only leads to a loss of Nox4-
dependent H2O2 formation, it also exhibited reduced p22phox
protein expression. Mutations of negatively charged amino acids at
the beginning of the N-terminus (E5A, E12A) or aliphatic amino
acid close to the predicted Nox1/2-p22phox interaction site
(I120C) had no inﬂuence on Nox4-dependent ROS production
(Fig. 6C and D). Interestingly, the Y121H mutation, previously de-
scribed by Banﬁ et al. in Cyba-deﬁcient mice [22] only resulted in
ROS formation in the tetracycline-induced Nox4-HEK293 cells,
whereas in the constitutive Nox4-HEK293 cells only a minimal
effect on ROS production was achieved. None of the mutants had a
dominant negative effect. I.e. transfection of the p22phox mutants
into HEK cells overexpressing Nox4 but expressing endogenous
p22phox had only a very minor effect on ROS formation (Sup.
Fig. 1).
These results highlight the importance of R90, the transmem-
brane region aa90-130 and also indicate importance for Y121 and
aa130-195 for Nox4 activity.4. Discussion
In this study using CRISPR/Cas9-mediated knockout cell lines
we demonstrate that p22phox deﬁcit completely abolishes Nox1
and Nox4 but not Nox5-dependent ROS production. In contrast,
Fig. 5. Nox1- or Nox5-dependent O2 production in p22phox-CRISPR/Cas9 knockout HEK293 cells. A, p22phox-knockout HEK293 cells (KO) or control cells (Vec) were
transiently transfected with control (Ctl) or human Nox5 overexpression (OE) plasmid and treated with PMA (100 nM, 30 min). Relative L012 assay of the transiently
transfected cells was performed. Also shown are representative Western blots for p22phox, Nox5 and β-Actin. B, Stably transduced Nox5-HEK293 cells were treated with
empty vector (Vec) or different gRNAs combinations targeting p22phox (combi. 1, 4, 7, 8, 10, 17) and treated with PMA (100 nM, 30 min). Relative L012 assay was performed.
Normalized, relative Western Blot for Nox5 and mRNA expression of p22phox (CYBA) are shown. C, p22phox-deﬁcient HEK293 cells (KO) or control cells (Vec) were transient
transfected with human NoxO1-NoxA1-Nox1 triple overexpression plasmid (OE) and treated with PMA (100 nM, 30 min). Relative L012 assay was performed. nZ3,
mean7SEM, ***po0.001.
K.-K. Prior et al. / Redox Biology 9 (2016) 287–295 293expression levels of these Nox enzymes were independent of
p22phox. The effect of the knockouts could be rescued with either
human or rat p22phox, but not with the DUOX-maturation factors
DUOXA1/A2. Truncation of p22phox till the amino acid 130 was
without a functional consequence, while further truncation leads
to a reduced function of the protein. Exchange of conserved ne-
gatively charged amino acids at the very N-terminus did not im-
pact on Nox4-dependent ROS formation, whereas the R90Q mu-
tant was not able to produce signiﬁcant amounts of ROS. Sur-
prisingly, the C-Terminus of p22phox was just dispensable in tet-
racycline-induced HEK293 cells. In constitutive Nox4-expressing
cells, truncation of p22phox with Q130stop could not rescue the
p22phox knockout. The same was observed for Y121H p22phox,
which just restored the ROS producing capacity of tetracycline-
induced Nox4. This might suggest that these parts of the protein
are important during the de novo formation of the Nox-p22phox
complex.
The functional interaction of the catalytically active Nox enzyme
with p22phox on ROS formation is in line with previous workemploying p22phox shRNA, siRNA or overexpression of Nox and
p22phox [16,17,19]. The rescue with either truncated Q130stop or
Y121H p22phox was described for co-overexpression of p22phox
and Nox4 [17]. This could be conﬁrmed with the tetracycline-in-
ducible Nox4 expression 24 h after the transfection with p22phox.
Therefore, Nox4 is transcribed, translated and matured after the
p22phox Q130stop or Y121H p22phox overexpression. In the con-
stitutively expressing Nox4-HEK293 cells, Nox4 is already expressed
in the absence of p22phox. Our data therefore suggest an involve-
ment of the C-terminal part of p22phox in the maturation of the
p22phox-Nox4 interaction. Since Nox4 is not dependent on cytosolic
subunits to form a functional Nox complex the role of p22phox is
rather stabilization then activation [9,23,29]. Nox1, Nox2 and Nox3
maturation and glycosylation have also been described to be
p22phox-dependent, but these isoforms are furthermore dependent
on the direct activation by p22phox by the prolin-rich region in the
C-terminus of p22phox [20,21]. This region is dispensable for Nox4
activation as shown in the tetNox4-HEKs and co-expression studies
by others [16,17].
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Fig. 6. Nox4-dependent H2O2 production with p22phox mutants in p22phox-CRISPR/Cas9 knockout HEK293 cells. Either subclonally expanded p22phox knockout (KO)
Nox4-HEK293 (C1-1 and C10-1; A and C) or induced tetNox4-HEK293 cells (C1-1 and C10-1; B and D) were transiently transfected (overexpression: OE) with full-length
human (hp22), truncated (*; stop (A and B)) or point mutated versions of p22phox (C and D). Relative luminol/HRP assay in Nox4-HEK293 (A and C) or induced tetNox4-
HEK293 cells (B and D) was performed. n¼6, mean7SEM, **po0.01; ***po0.001, relative to the corresponding p22phox (hp22) transfected cells.
K.-K. Prior et al. / Redox Biology 9 (2016) 287–295294Zhu et al. described the dependence of Nox2 maturation on
amino acids 6-142 [31]. Therefore we propose that also Nox4
maturation is dependent on the amino acids 6-130. In line with
this, deletion of the ﬁrst ﬁve amino acids, but not 11 amino acids,
is tolerated by Nox4 as shown in a previous study [17]. Con-
troversially, a peptide targeting the amino acids 6-11 (WAMWAN)
did not inhibit Nox4-derived ROS production [8]. Furthermore, it
was also reported that the D-Loop of Nox4 is responsible for the
Nox4-p22phox activation suggesting an ionic interaction [18]. We
tested if substitution of inter-species conserved negatively charged
glutamic acid in the N-terminal region inﬂuence Nox4 activity.
Neither E5A nor E12 A reduced Nox4 activity in p22phox-deﬁcient
HEK293 cells. Further studies on the structural relevance of the
N-Terminus for Nox4 maturation and activity are thus needed to
understand the mechanism underlying p22phox function.
For Nox1-3 a 1:1 p22phox heterocomplex formation is pro-
posed for the activation and assembly of functional Nox complexes
at the plasma membrane, whereas Nox5 forms homooligomers
and does not require p22phox [15]. In this and in other studies
Nox4 overexpression yielded high ROS production with en-
dogenous p22phox [2,12,16,26]. In HEK293 cells, co-over-
expression of p22phox or its mutants did not further increase ROS
production. This effect, however, is cell-type speciﬁc and in other
cells, like COS-7 or PLB cells, basal p22phox mRNA expression
might be insufﬁcient to provide sufﬁcient protein to the Nox en-
zyme. Maturation of Nox enzymes in general is a complex process
and other proteins, like protein disulﬁde isomerase [13] or Cal-
nexin [24] also contribute to the process. Further studies are
needed to understand the process in detail to dissect the precise
mode of p22phox – Nox interaction.
In summary, we used CRISPR/Cas9-technology to reliably and
rapidly alter genomic CYBA DNA sequences and induced a knock-
out of p22phox in two Nox4-overexpressing cell lines. We de-
monstrated that rapid deletion of p22phox is possible and that theactivity of Nox1 and Nox4 but not Nox5 exclusively depends on
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